The initial public offer (IPO) of Medistep Healthcare received bids for 3,26,01,000 shares as against 37,44,000 shares on offer, as per NSE data as of 17:00 hours on Friday (08 August 2025). The issue was subscribed 8.71 times.
The issue opened for bidding on Friday (08 August 2025) and it will close on Tuesday (12 August 2025). The price of the IPO is fixed at Rs 43 per share. The minimum order quantity is 3,000 equity shares. The equity shares will list on NSE’s SME platform.
The IPO comprises fresh issue of 37,44,000 equity shares. The promoter and promoter group shareholding will dilute to 68.96% from 93.62% pre-issue.
About 1,89,000 equity shares will be reserved for subscription by market maker to the issue. The net offer comprises of 35,55,000 equity shares. The offer and the net offer will constitute 26.34% and 25.01%, respectively of the post issue paid up equity share capital of the company.
The company intends to utilize the net proceeds for funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility, working capital requirements and general corporate purpose.
Medistep Healthcare is a pharmaceutical company that has carved a niche in the Healthcare Industry through its experience in manufacturing Sanitary pads, Energy powder and trading a diverse range of pharmaceutical products, Nutraceutical products, Intimate Products and surgical products through distribution network. As of 20 July 2025, the company had total of 9 employees.
The company recorded revenue from operations of Rs 49.65 crore and net profit of Rs 4.14 crore for the period ended 31 March 2025.